Witnesses
The following witnesses gave evidence. Transcripts can be viewed on the inquiry publications page of the Committee’s website.
Wednesday 1 November 2017 Question number
|
Dr Magdalini Papadaki, Head of Product and Process Innovation, Association of the British Pharmaceutical Industry; and Professor Sir John Bell, Regius Professor of Medicine, University of Oxford |
|
|
Dr Mark Kroese, Chair, Diagnostics Advisory Committee, National Institute for Health and Care Excellence; Professor Sue Hill, Chief Scientific Officer for England, NHS England; and Professor William Newman, Vice Chair, British Society for Genetic Medicine |
Tuesday 28 November 2017
|
Dr Hilary Burton, Consultant in Public Health, PHG Foundation; Professor Sian Ellard, Clinical Programme Director, South West NHS Genomic Medicine Centre; and Fiona Murphy, Director, National Services Division, NHS National Services Scotland, and Member of the Scottish Genomes Partnership |
|
|
Lord O’Shaughnessy, Parliamentary Under-Secretary of State, Department of Health; Professor Dame Sally Davies, Chief Medical Officer for England; and Professor Patrick Chinnery, Professor of Neurology, Cambridge University |
Published: 20 April 2018